Eli Lilly continues genetic medicine push with $1.9bn Ascidian partnership

Pharmaceutical Technology

Eli Lilly's deal with Ascidian is one of several that the pharma giant has cut within the realm of genetic medicines.

pharminent June 4, 2026 (Last updated: June 4, 2026)

Pharmaceutical Technology

Eli Lilly’s deal with Ascidian is one of several that the pharma giant has cut within the realm of genetic medicines.

Related Stories